PHF2 regulates sarcomeric gene transcription in myogenesis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0301690 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Taku Fukushima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Medicine, Aichi Medical University, Nagakute, Aichi, Japan. Hauptthemen laut MEDLINE: Muscle Development, Sarcomeres. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Nakatomi Foundation.
Abstract (Originalsprache)
Myogenesis is regulated mainly by transcription factors known as Myogenic Regulatory Factors (MRFs), and the transcription is affected by epigenetic modifications. However, the epigenetic regulation of myogenesis is poorly understood. Here, we focused on the epigenomic modification enzyme, PHF2, which demethylates histone 3 lysine 9 dimethyl (H3K9me2) during myogenesis. Phf2 mRNA was expressed during myogenesis, and PHF2 was localized in the nuclei of myoblasts and myotubes. We generated Phf2 knockout C2C12 myoblasts using the CRISPR/Cas9 system and analyzed global transcriptional changes via RNA-sequencing. Phf2 knockout (KO) cells 2 d post differentiation were subjected to RNA sequencing. Gene ontology (GO) analysis revealed that Phf2 KO impaired the expression of the genes related to skeletal muscle fiber formation and muscle cell development. The expression levels of sarcomeric genes such as Myhs and Mybpc2 were severely reduced in Phf2 KO cells at 7 d post differentiation, and H3K9me2 modification of Mybpc2 , Mef2c and Myh7 was increased in Phf2 KO cells at 4 d post differentiation. These findings suggest that PHF2 regulates sarcomeric gene expression via epigenetic modification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology, School of Medicine, Aichi Medical University, Nagakute, Aichi, Japan.
- Department of Nutritional Physiology, Institute of Medical Nutrition, Tokushima University Graduate School, Tokushima, Japan.
ORCID-Profile: Satoru Masubuchi, Iori Sakakibara
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Nakatomi Foundation
- Nitto
- Takeda Foundation
Zitieren
APA
Fukushima, T., Hasegawa, Y., Kuse, S., Fujioka, T., Nikawa, T., Masubuchi, S., & Sakakibara, I. (2024). PHF2 regulates sarcomeric gene transcription in myogenesis. PLOS ONE. https://doi.org/10.1371/journal.pone.0301690
Vancouver
Fukushima T, Hasegawa Y, Kuse S, Fujioka T, Nikawa T, Masubuchi S, et al. PHF2 regulates sarcomeric gene transcription in myogenesis. PLOS ONE. 2024. doi:10.1371/journal.pone.0301690
BibTeX
@article{Fukushima2024,
author = {Fukushima, Taku and Hasegawa, Yuka and Kuse, Sachi and Fujioka, Taiju and Nikawa, Takeshi and Masubuchi, Satoru and Sakakibara, Iori},
title = {PHF2 regulates sarcomeric gene transcription in myogenesis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0301690}
}
EUVIMED